adxs-503
Generic: Attenuated Live Listeria monocytogenes Encoding KRAS G12D·Code: ADXS-503
adxs-503: developed by 2 companies. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| OLD AYALA, INC (AYLA) | Preclinical |
| OS Therapies Inc (OSTX) | Preclinical |
Get deeper analysis on adxs-503
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis